FLNA · Filana Therapeutics Inc
United States · RS rating 8 · As of 2026-11-03
| Price | 0.59 USD |
|---|---|
| 1-day change | +6.1% |
| RS rating (overall / 1M / 3M / 12M) | 8 / 11 / 15 / 8 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 13 / 3 / 31 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -18.2% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +82.5% |
| Market cap (USD) | $80.2M |